1-3 of 3
Deborah Blamble, PHDP
Close
Sort by
Journal Articles

Outcome of First Salvage Therapy in Core Binding Factor Associated Acute Myelogenous Leukemia Is Less Than Optimal

Carmen Fava, MD, Deborah Blamble, PHDP, Susan O’Brien, M.D., Guillermo Garcia-Manero, MD, Sherry Pierce, Hagop Kantarjian, MD, Gautam Borthakur, MD
Journal: Blood
Blood (2008) 112 (11): 2952.
https://doi.org/10.1182/blood.V112.11.2952.2952
Published: 2008
Journal Articles

An Interim Analysis of Phase II, Open Randomized Comparative Trial: Alternate or Multiple-Day Dosing of Palonosetron (PALO) Is Effective and Safe in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients (pts) with Leukemia Receiving High Dose Ara-C (HDAC).

Gloria Mattiuzzi, MD, Jorge Cortes, MD, Jennifer Cassat, Deborah Blamble, PHDP, B. Nebiyou Bekele, PhD, Miloslav Beran, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Jan Burger, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2007) 110 (11): 2840.
https://doi.org/10.1182/blood.V110.11.2840.2840
Published: 2007
Journal Articles

Liposomal Amphotericin B IV (LIPO AB) Once Per Week Is Effective in the Prevention of Invasive Fungal Infections (IFI) in Patients (Pts) with Acute Leukemia: Preliminary Analysis of a Randomized Trial.

Gloria Mattiuzzi, MD, Jorge Cortes, MD, Deborah Blamble, PHDP, Elihu Estey, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2007) 110 (11): 1824.
https://doi.org/10.1182/blood.V110.11.1824.1824
Published: 2007